Diffuse large B-cell lymphoma trials in Brazil
8 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleEffectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies
- Where
- Curitiba, Minas Gerais, Salvador, São Paulo
- Age
- 0 years to 100 years
- People
- 200
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05541341 - Phase 3Taking peopleA Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Where
- Cascavel, Curitiba, Florianópolis, Natal, Ribeirão Preto, São Carlos, São Paulo, SJRP
- Age
- 18 years and over
- People
- 1,046 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06717347 · EU 2024-515566-13-00 - Phase 3Taking peopleA Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
- Where
- Barretos, Belo Horizonte, Bento Gonçalves, Brasília, Cascavel, Curitiba, Jaú, Joinville, Lages, Natal, Porto Alegre, Rio de Janeiro, Salvador, São Paulo
- Age
- 18 years and over
- People
- 904 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06091865 · EU 2022-502785-25-00 - Phase 2/3Taking peopleA Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
- Where
- Curitiba, Natal, São Paulo
- Age
- 18 years and over
- People
- 290 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05139017 · EU 2022-502646-27-00 - Phase 2Taking peopleStudy of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
- Where
- Barretos, Belo Horizonte, Brasília, Campinas, Curitiba, Florianópolis, Goiânia, Natal, Porto Alegre, Recife, Ribeirão Preto, Rio de Janeiro, São José do Rio Preto, São Luís, São Paulo, Sorocaba
- Age
- 65 years to 99 years
- People
- 80 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05952024 - Phase 1/2Taking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Barretos, Curitiba, Porto Alegre, São José do Rio Preto
- Age
- 6 months to 25 years
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - No phaseNot yet taking people in BrazilA Study to Evaluate Treatment Patterns and Investigate Adult Patients With B-cell Lymphoma
- Where
- Campinas, Curitiba, São Paulo
- Age
- 18 years and over
- People
- 532
- Run by
- AstraZeneca
See details and how to joinNCT07882576 - Phase 1/2Taking peopleA Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Brasília, Curitiba, Porto Alegre, São Paulo
- Age
- 18 years and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00